E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/8/2013 in the Prospect News PIPE Daily.

MedWorth greenshoe exercised for $60.72 million IPO of common stock

Deal sells shares via underwriter EarlyBirdCapital and Aegis Capital

By Devika Patel

Knoxville, Tenn., July 8 - MedWorth Acquisition Corp. said the underwriters for its initial public offering of stock opted to exercise the deal's $7.92 million greenshoe in full for total proceeds of $60.72 million on July 3. The deal priced for $48 million with a $7.2 million greenshoe on May 20 and was increased to $52.8 million with a $7.92 million greenshoe on June 28.

The company sold 7.59 million common shares at $8.00 per share. Of the shares, 990,000 comprised the fully exercised greenshoe.

EarlyBirdCapital, Inc. was the underwriter. Aegis Capital Corp. also assisted.

Proceeds will be used for fees, expenses, working capital and general corporate purposes.

The blank check company focuses on the U.S. specialty pharmacy, infusion pharmacy and drug distribution sectors and is based in Miami.

Issuer:MedWorth Acquisition Corp.
Issue:Common stock
Amount:$60.72 million (including $7.92 million greenshoe)
Shares:7.59 million
Price:$8.00
Warrants:No
Underwriter:EarlyBirdCapital, Inc.
Pricing date:May 20
Upsized:June 26
Settlement date:July 3
Stock exchange:Nasdaq: MWRX

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.